191 related articles for article (PubMed ID: 25558647)
21. The effect of omalizumab on nasal allergic inflammation.
Plewako H; Arvidsson M; Petruson K; Oancea I; Holmberg K; Adelroth E; Gustafsson H; Sandström T; Rak S
J Allergy Clin Immunol; 2002 Jul; 110(1):68-71. PubMed ID: 12110823
[TBL] [Abstract][Full Text] [Related]
22. Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis.
Corren J; Diaz-Sanchez D; Saxon A; Deniz Y; Reimann J; Sinclair D; Davancaze T; Adelman D
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):243-8. PubMed ID: 15478383
[TBL] [Abstract][Full Text] [Related]
23. DMBT1 has a protective effect on allergic rhinitis.
Zhao Y; Tao Q; Wu J; Liu H
Biomed Pharmacother; 2020 Jan; 121():109675. PubMed ID: 31810134
[TBL] [Abstract][Full Text] [Related]
24. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial.
Casale TB; Condemi J; LaForce C; Nayak A; Rowe M; Watrous M; McAlary M; Fowler-Taylor A; Racine A; Gupta N; Fick R; Della Cioppa G;
JAMA; 2001 Dec; 286(23):2956-67. PubMed ID: 11743836
[TBL] [Abstract][Full Text] [Related]
25. [Effect of nasal glucocorticoid combined with loratadine or montelukast on allergic rhinitis].
Jia MH; Chen XY; Zhang Y; Liao ZS
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):369-373. PubMed ID: 29871264
[No Abstract] [Full Text] [Related]
26. Intranasal administration of CpG oligodeoxynucleotides reduces lower airway inflammation in a murine model of combined allergic rhinitis and asthma syndrome.
Li HT; Zhang TT; Chen ZG; Ye J; Liu H; Zou XL; Wang YH; Yang HL
Int Immunopharmacol; 2015 Sep; 28(1):390-8. PubMed ID: 26163938
[TBL] [Abstract][Full Text] [Related]
27. The effects of mometasone furoate and strontium chloride in a rat model of allergic rhinitis.
Altuntaş EE; Doğan ÖT; Saraç B; Turgut NH; Durmuş K; Akyol M
Ear Nose Throat J; 2018; 97(1-2):E1-E7. PubMed ID: 29493722
[TBL] [Abstract][Full Text] [Related]
28. Suppressive Activity of Adiponectin on the Development of Allergic Rhinitis in Mice.
Furukawa S; Asano K; Kobayashi H
In Vivo; 2019; 33(1):93-98. PubMed ID: 30587608
[TBL] [Abstract][Full Text] [Related]
29. The Anti-Allergic Rhinitis Effect of Traditional Chinese Medicine of Shenqi by Regulating Mast Cell Degranulation and Th1/Th2 Cytokine Balance.
Shao YY; Zhou YM; Hu M; Li JZ; Chen CJ; Wang YJ; Shi XY; Wang WJ; Zhang TT
Molecules; 2017 Mar; 22(3):. PubMed ID: 28327534
[TBL] [Abstract][Full Text] [Related]
30. Establishment of an allergic rhinitis model in mice for the evaluation of nasal symptoms.
Tsunematsu M; Yamaji T; Kozutsumi D; Murakami R; Kimura S; Kino K
Life Sci; 2007 Mar; 80(15):1388-94. PubMed ID: 17300813
[TBL] [Abstract][Full Text] [Related]
31. Suppression of neuropeptide production by quercetin in allergic rhinitis model rats.
Kashiwabara M; Asano K; Mizuyoshi T; Kobayashi H
BMC Complement Altern Med; 2016 May; 16():132. PubMed ID: 27207147
[TBL] [Abstract][Full Text] [Related]
32. Differential responses to various classes of drugs in a model of allergic rhinitis in guinea pigs.
Al Suleimani YM; Dong Y; Walker MJ
Pulm Pharmacol Ther; 2008; 21(2):340-8. PubMed ID: 17905620
[TBL] [Abstract][Full Text] [Related]
33. [Effect and mechanism of IL-1β/JNK transduction pathway on the nasal mucosa remodeling in allergic rhinitis rats].
Gu X; Li Q; Chen Y; Ma Y; Zhang Y; Sun C; You C
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Feb; 30(3):226-9. PubMed ID: 27373094
[TBL] [Abstract][Full Text] [Related]
34. Antileukotriene treatment and allergic rhinitis-related cough in guinea pigs.
Brozmanova M; Plevkova J; Bartos V; Plank L; Tatar M
J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():21-30. PubMed ID: 16204773
[TBL] [Abstract][Full Text] [Related]
35. Skullcapflavone II attenuates ovalbumin-induced allergic rhinitis through the blocking of Th2 cytokine production and mast cell histamine release.
Bui TT; Piao CH; Song CH; Chai OH
Int Immunopharmacol; 2017 Nov; 52():77-84. PubMed ID: 28886581
[TBL] [Abstract][Full Text] [Related]
36. Intraperitoneal mesenchymal stem cell administration ameliorates allergic rhinitis in the murine model.
Işık S; Karaman M; Adan A; Kıray M; Bağrıyanık HA; Sözmen ŞÇ; Kozanoğlu İ; Karaman Ö; Baran Y; Uzuner N
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):197-207. PubMed ID: 27380271
[TBL] [Abstract][Full Text] [Related]
37. TLR4 antagonist ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing inflammatory monocytes infiltration in mice model.
Tang H; Li T; Han X; Sun J
Int Immunopharmacol; 2019 Aug; 73():254-260. PubMed ID: 31121415
[TBL] [Abstract][Full Text] [Related]
38. Etiopathogenesis and management of perennial allergic rhinitis: a state-of-the-art review.
Bush RK
Treat Respir Med; 2004; 3(1):45-57. PubMed ID: 15174893
[TBL] [Abstract][Full Text] [Related]
39. The effects of resiquimod in an ovalbumin-induced allergic rhinitis model.
Qu S; Qin T; Li M; Zhang S; Ye L; Wei J; Fan H; Chen B
Int Immunopharmacol; 2018 Jun; 59():233-242. PubMed ID: 29665497
[TBL] [Abstract][Full Text] [Related]
40. [Effect of RORC inhibitor on HIF-1α and VEGF in nasal mucosa of allergic rhinitis of mice].
Wei PC; Tong L; Li R
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Oct; 53(10):751-756. PubMed ID: 30347534
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
